450 related articles for article (PubMed ID: 31176616)
1. Targeting ADP-ribosylation as an antimicrobial strategy.
Catara G; Corteggio A; Valente C; Grimaldi G; Palazzo L
Biochem Pharmacol; 2019 Sep; 167():13-26. PubMed ID: 31176616
[TBL] [Abstract][Full Text] [Related]
2. ADP-ribosylation signalling and human disease.
Palazzo L; Mikolčević P; Mikoč A; Ahel I
Open Biol; 2019 Apr; 9(4):190041. PubMed ID: 30991935
[TBL] [Abstract][Full Text] [Related]
3. Systems-wide Analysis of Serine ADP-Ribosylation Reveals Widespread Occurrence and Site-Specific Overlap with Phosphorylation.
Larsen SC; Hendriks IA; Lyon D; Jensen LJ; Nielsen ML
Cell Rep; 2018 Aug; 24(9):2493-2505.e4. PubMed ID: 30157440
[TBL] [Abstract][Full Text] [Related]
4. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
5. Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation.
Buch-Larsen SC; Hendriks IA; Lodge JM; Rykær M; Furtwängler B; Shishkova E; Westphall MS; Coon JJ; Nielsen ML
Cell Rep; 2020 Sep; 32(12):108176. PubMed ID: 32966781
[TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation: An emerging direction for disease treatment.
Liu YT; Che Y; Qiu HL; Xia HX; Feng YZ; Deng JY; Yuan Y; Tang QZ
Ageing Res Rev; 2024 Feb; 94():102176. PubMed ID: 38141734
[TBL] [Abstract][Full Text] [Related]
7. Serine is the major residue for ADP-ribosylation upon DNA damage.
Palazzo L; Leidecker O; Prokhorova E; Dauben H; Matic I; Ahel I
Elife; 2018 Feb; 7():. PubMed ID: 29480802
[TBL] [Abstract][Full Text] [Related]
8. Studying Catabolism of Protein ADP-Ribosylation.
Palazzo L; James DI; Waddell ID; Ahel I
Methods Mol Biol; 2017; 1608():415-430. PubMed ID: 28695524
[TBL] [Abstract][Full Text] [Related]
9. Specificity of reversible ADP-ribosylation and regulation of cellular processes.
Crawford K; Bonfiglio JJ; Mikoč A; Matic I; Ahel I
Crit Rev Biochem Mol Biol; 2018 Feb; 53(1):64-82. PubMed ID: 29098880
[TBL] [Abstract][Full Text] [Related]
10. ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives.
Manco G; Lacerra G; Porzio E; Catara G
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327636
[TBL] [Abstract][Full Text] [Related]
11. Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling.
Fontana P; Buch-Larsen SC; Suyari O; Smith R; Suskiewicz MJ; Schützenhofer K; Ariza A; Rack JGM; Nielsen ML; Ahel I
Nat Commun; 2023 Jun; 14(1):3200. PubMed ID: 37268618
[TBL] [Abstract][Full Text] [Related]
12. Host poly(ADP-ribose) polymerases (PARPs) in acute and chronic bacterial infections.
Miettinen M; Vedantham M; Pulliainen AT
Microbes Infect; 2019 Dec; 21(10):423-431. PubMed ID: 31207286
[TBL] [Abstract][Full Text] [Related]
13. The fast-growing business of Serine ADP-ribosylation.
Longarini EJ; Matic I
DNA Repair (Amst); 2022 Oct; 118():103382. PubMed ID: 35963141
[TBL] [Abstract][Full Text] [Related]
14. Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders.
Faraoni I; Giansanti M; Voso MT; Lo-Coco F; Graziani G
Biochem Pharmacol; 2019 Sep; 167():133-148. PubMed ID: 31028744
[TBL] [Abstract][Full Text] [Related]
15. ADP-ribosylation and intracellular traffic: an emerging role for PARP enzymes.
Grimaldi G; Corda D
Biochem Soc Trans; 2019 Feb; 47(1):357-370. PubMed ID: 30710058
[TBL] [Abstract][Full Text] [Related]
16. An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation.
Bonfiglio JJ; Leidecker O; Dauben H; Longarini EJ; Colby T; San Segundo-Acosta P; Perez KA; Matic I
Cell; 2020 Nov; 183(4):1086-1102.e23. PubMed ID: 33186521
[TBL] [Abstract][Full Text] [Related]
17. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
18. Insights into the biogenesis, function, and regulation of ADP-ribosylation.
Cohen MS; Chang P
Nat Chem Biol; 2018 Feb; 14(3):236-243. PubMed ID: 29443986
[TBL] [Abstract][Full Text] [Related]
19. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders.
Grimaldi G; Catara G; Palazzo L; Corteggio A; Valente C; Corda D
Biochem Pharmacol; 2019 Sep; 167():64-75. PubMed ID: 31102582
[TBL] [Abstract][Full Text] [Related]
20. Multiple Roles for Mono- and Poly(ADP-Ribose) in Regulating Stress Responses.
Qi H; Price BD; Day TA
Trends Genet; 2019 Feb; 35(2):159-172. PubMed ID: 30595401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
